Infectious Disease News Current Issue
The following articles appeared in the print edition of Infectious Disease News.
Table of Contents
- STDs pose major health threat to MSM
-
- Georgia launches HCV elimination program with help from CDC
- Gilead files NDA for once-daily HIV treatment
- House passes bill to bolster drug development, streamline clinical testing
- Parents view vaccine safety, benefits more favorably
- Phase 1 trial of West Nile virus vaccine begins
- Phase 3 trial of vaginal ring to prevent HIV reaches completion
- Simple ID prevention practices crucial for international travelers
- The physician as the health economist: A necessity of today Michael S. Saag, MD
-
- Tick tick, can make you sick Donald Kaye, MD, MACP
- FDA approves Technivie for HCV genotype 4
- FDA approves HIV infection type assay
- Alisporivir plus ribavirin yields high response rates for HCV genotype 3
- Combination therapy effective for HIV patients with visceral leishmaniasis
- Complera well-tolerated as PEP in MSM
- Blood-free transdermal device tests for malaria in seconds
- Early ART beneficial for newly diagnosed TB patients with low CD4
-
- Ebola vaccine candidate highly effective in phase 3 trial
- EBOV remains viable for several days under treatment unit conditions
- Emerging norovirus strain triggers gastroenteritis outbreaks in China
- European swine flu may target immunocompromised
- Expert panel releases prevention recommendations for nosocomial C. difficile
- H. pylori eradication may reduce gastric cancer incidence
- Harvoni shows promise for HCV genotype 4
- Health care textiles rarely contaminated when washed, stored properly
-
- Hepatitis B vaccine boosters unneeded for patients with residual anti-HBs
- Hospitals continue to use contact precautions to control MRSA spread
- Increasing secondary education reduces HIV infection rates
- Infection prevention methods in US vary after cesarean delivery
- Infections responsible for 28% of hospital readmissions
- Legionnaires’ disease organism sources largely unknown
- Liberians struggle to identify Ebola
- Melioidosis cases increase slightly in US
-
- Military personnel returning to US pose low risk for Ebola transmission
- Mortality risk greater in children with severe C. difficile, chronic conditions
- New assay may help predict progression of HCV genotype 1b
- Novel drug candidate thwarts HIV reactivation
- Novel method identifies FDA-approved antacid as candidate TB treatment
- Only two states require HPV vaccination
- Opioid substitution therapy reduces HIV-, drug-related mortality among individuals with HIV, drug addiction
- P. aeruginosa survives in sinks 10 years after hospital outbreak
-
- Physicians urged to consider alternative treatments for at-risk pneumonia patients
- Proactive prevention measures limit nosocomial infections
- Repeated deworming of children fails to reduce malaria rate
- Research on underexamined animal infections benefits human health
- Researchers urge additional investment in global health aid
- Risk for hospitalization from community-acquired pneumonia significantly higher in older adults
- Single measles exposure led to $5,600 in clinic costs
- Software identifies sources of fecal water contamination
-
- Study shows low SVR among veterans on Sovaldi-based regimens
- Surveillance program identifies hepatitis disease patterns in India
- Televised Ebola news coverage influences social media panic
- TTE appears viable for managing low-risk S. aureus bacteremia
- Vaccine program protects Australian women against 4vHPV
- Valley fever cases rise in Missouri
- Risk for MERS-CoV importation to Canada low
- Immune cells in HIV nonprogressors metabolize cholesterol more effectively
-
- Perinatally infected HIV patient maintains remission 11 years after therapy
- TDF2 OLE: High PrEP adherence results in zero infections
- C. difficile: Infection prevention and pharmacy considerations Kati Shihadeh, PharmD, BCIDP; Brandon Ferlas, PharmD, MS